RSS-Feed abonnieren
PDF herunterladen
DOI: 10.1055/s-0042-1757542
Tuberculosis is a Common Cause of Post-Liver Transplant Ascites: An Observational Study
Funding None.
Abstract
Background Ascites is expected to resolve within 2 to 4 weeks following orthotopic liver transplantation. New-onset ascites after transplant is associated increased morbidity and affects quality of life. The risk of opportunistic infections is high in transplant recipients due to immunosuppressive drugs.
Objective The objective was to assess the incidence of new-onset ascites in the transplant recipients and describe the cause and course of the same.
Methods We retrospectively collected data of all the patients who underwent liver transplantation at our center from April 1, 2020 to April 1, 2021. The details of patients developing ascites post-liver transplantation were retrieved. The patients were followed up for 1 year after transplant.
Results A total of 95 patients underwent living donor liver transplantation at our center. The incidence of new-onset ascites was 8.42% (8/95). Six out eight patients were diagnosed with tubercular ascites of whom one had disseminated tuberculosis. None of the patients had concomitant pulmonary tuberculosis. Ascites secondary to hypoalbuminemia was reported in two patients. Immunoglobulin A nephropathy and tacrolimus therapy were the underlying causes of proteinuria.
Conclusion Tuberculosis was the leading cause of ascites in post-transplant period in our study. Tuberculosis should be considered as a differential diagnosis while evaluating these patients especially in the Asia-Pacific region. Being a potentially curable cause, timely diagnosis and treatment significantly improves graft survival.
Keywords
liver transplantation - mycobacterium tuberculosis (MTB) - IgA nephropathy - post-transplant tuberculosis - tuberculous peritonitis - peritoneal tuberculosisEthical Statement
Approved vide letter number AIG/IEC- BH&R 29106.2022-03. Need for consent waived because of retrospective nature of the study.
Author Contributions
A.V.K. contributed to the study concept. S.T.R., A.V.K., R.R., B.P.M. contributed to data collection. S.T.R. contributed to statistical analysis and compilation. A.V.K., M.S., D.N.R. and P.N.R. contributed for critical revision and final approval of draft.
Data Availability Statement
The data can be obtained from the corresponding author on a reasonable request.
Publikationsverlauf
Eingereicht: 22. Januar 2022
Angenommen: 03. April 2022
Artikel online veröffentlicht:
22. September 2023
© 2022. Gastroinstestinal Infection Society of India. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Jenkins M, Satoskar R. Ascites after liver transplantation-review. Clin Liver Dis (Hoboken) 2021; 17 (04) 317-319
- 2 Gotthardt DN, Weiss KH, Rathenberg V, Schemmer P, Stremmel W, Sauer P. Persistent ascites after liver transplantation: etiology, treatment and impact on survival. Ann Transplant 2013; 18: 378-383
- 3 Stewart CA, Wertheim J, Olthoff K. et al. Ascites after liver transplantation–a mystery. Liver Transpl 2004; 10 (05) 654-660
- 4 Cirera I, Navasa M, Rimola A. et al. Ascites after liver transplantation. Liver Transpl 2000; 6 (02) 157-162
- 5 Olithselvan A, Rajagopala S, Vij M, Shanmugam V, Shanmugam N, Rela M. Tuberculosis in liver transplant recipients: experience of a South Indian liver transplant center. Liver Transpl 2014; 20 (08) 960-966
- 6 Matsudaira S, Ishizaki Y, Yoshimoto J, Fujiwara N, Kawasaki S. Risk factors for intractable ascites after adult-to-adult living donor liver transplantation using left lobe. Transplant Direct 2017; 3 (03) e138
- 7 Bhargava DK, Gupta M, Nijhawan S, Dasarathy S, Kushwaha AK. Adenosine deaminase (ADA) in peritoneal tuberculosis: diagnostic value in ascitic fluid and serum. Tubercle 1990; 71 (02) 121-126
- 8 Lewinsohn DM, Leonard MK, LoBue PA. et al. Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: diagnosis of tuberculosis in adults and children. Clin Infect Dis 2017; 64 (02) 111-115
- 9 Sharma V, Soni H, Kumar-M P. et al. Diagnostic accuracy of the Xpert MTB/RIF assay for abdominal tuberculosis: a systematic review and meta-analysis. Expert Rev Anti Infect Ther 2021; 19 (02) 253-265
- 10 Alizadeh AM, Marjani M, Moniri A. et al. Tuberculosis in solid organ transplantation. Tanaffos 2016; 15 (03) 124-127
- 11 Bumbacea D, Arend SM, Eyuboglu F. et al. The risk of tuberculosis in transplant candidates and recipients: a TBNET consensus statement. Eur Respir J 2012; 40 (04) 990-1013
- 12 Çelikbilek M, Selçuk H, Yilmaz U. The effect of hepatotropic virus (HBV-HCV) infections on tuberculin skin test in patients with cirrhosis. Turk J Gastroenterol 2012; 23 (03) 234-238
- 13 Agarwal R. Treatment of latent tuberculous infection in India: is it worth the salt?. Lung India 2005; 22 (04) 105-106
- 14 Agarwal SK, Gupta S, Bhowmik D, Mahajan S. Tuberculin skin test for the diagnosis of latent tuberculosis during renal replacement therapy in an endemic area: a single center study. Indian J Nephrol 2010; 20 (03) 132-136
- 15 Jamshidi M, Geramizadeh B, Heiran A. et al. Diagnosis of latent tuberculosis in liver transplant candidates, a single center experience. Clin Lab 2021; 67 (01)
- 16 Singh N, Paterson DL. Mycobacterium tuberculosis infection in solid-organ transplant recipients: impact and implications for management. Clin Infect Dis 1998; 27 (05) 1266-1277
- 17 John GT, Shankar V, Abraham AM, Mukundan U, Thomas PP, Jacob CK. Risk factors for post-transplant tuberculosis. Kidney Int 2001; 60 (03) 1148-1153
- 18 Subramanian A, Dorman S. AST Infectious Diseases Community of Practice. Mycobacterium tuberculosis in solid organ transplant recipients. Am J Transplant 2009; 9 (4, Suppl 4) S57-S62
- 19 Randhawa PS, Starzl TE, Demetris AJ. Tacrolimus (FK506)-associated renal pathology. Adv Anat Pathol 1997; 4 (04) 265-276
- 20 Shen T, Feng XW, Geng L, Zheng SS. Reversible sinusoidal obstruction syndrome associated with tacrolimus following liver transplantation. World J Gastroenterol 2015; 21 (20) 6422-6426
- 21 Hosseini M, Aliakbarian M, Akhavan-Rezayat K, Shadkam O, Milani S. Tacrolimus- induced ascites after liver transplant. Int J Organ Transplant Med 2018; 9 (02) 102-104
- 22 O'Riordan A, Dutt N, Cairns H. et al. Renal biopsy in liver transplant recipients. Nephrol Dial Transplant 2009; 24 (07) 2276-2282
- 23 Leong LY, Lin PC, Chi CY. et al. Risk factors of tuberculosis after liver transplant in a tertiary care hospital. J Microbiol Immunol Infect 2021; 54 (02) 312-318
- 24 Holty JE, Gould MK, Meinke L, Keeffe EB, Ruoss SJ. Tuberculosis in liver transplant recipients: a systematic review and meta-analysis of individual patient data. Liver Transpl 2009; 15 (08) 894-906